Treatment of disseminated candidiasis with 5-fluorocytosine.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000935:Antifungal Agents / Q000627:therapeutic use*; D002177:Candidiasis / Q000188:drug therapy*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D003596:Cytosine / Q000627:therapeutic use*; D004802:Eosinophilia / Q000139:chemically induced; D005260:Female; D005437:Flucytosine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged
D000935:Antifungal Agents; D003596:Cytosine; D005437:Flucytosine